Norbert G Riedel's Net Worth
$18.2 Million
Who is Norbert G Riedel?
Norbert G Riedel has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include GENENCOR INTERNATIONAL INC, Jazz Pharmaceuticals plc, Cerevel Therapeutics Holdings, Inc., Eton Pharmaceuticals, Inc., Aptinyx Inc., ARIAD PHARMACEUTICALS INC, BAXTER INTERNATIONAL INC, and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
Norbert G Riedel's CIK is 0001161662
Past Insider Trading and Trends
2003 was Norbert G Riedel's most active year for acquiring shares with 16 total transactions. Norbert G Riedel's most active month to acquire stocks was the month of December. 2009 was Norbert G Riedel's most active year for disposing of shares, totalling 13 transactions. Norbert G Riedel's most active month to dispose stocks was the month of July. 2010 saw Norbert G Riedel paying a total of $3,745,224.00 for 127,123 shares, this is the most they've acquired in one year. In 2009 Norbert G Riedel cashed out on 391,705 shares for a total of $11,220,702.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENENCOR INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -300.00 |
$19.25 | -$5,775.00 |
0
|
Apr 20 - Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.45% | 1.83K |
$138.16 | -$171,454.20 | 13.71K |
Aug 11 - Aug 14
| |||
Form 4
| +14.16% | 1.47K |
$105.36 | -$970,556.92 | 11.87K |
Aug 5 - Aug 8
| |||
Form 4
| -11.16% | -1.31K |
$147.96 | -$193,235.76 | 10.4K |
Aug 6
| |||
Form 4
| +23.74% | 2.25K |
—
|
—
| 11.71K |
Jul 29
| |||
Form 4
| +23.08% | 1.77K |
$125.87 | -$117,185.71 | 9.46K |
Aug 6 - Aug 7
| |||
Form 4
| +18.39% | 1.19K |
$135.65 | -$98,481.68 | 7.68K |
Aug 8 - Aug 9
| |||
Form 4
| +14.76% | 835 |
$176.61 | -$116,563.06 | 6.49K |
Aug 9 - Aug 10
| |||
Form 4
| +14.19% | 703 |
$142.37 | -$94,247.63 | 5.66K |
Aug 10 - Aug 11
| |||
Form 4
| -11.33% | -633.00 |
$136.45 | -$86,372.85 | 4.95K |
Aug 15
| |||
Form 4
| +32.34% | 1.36K |
—
|
—
| 5.59K |
Aug 11
| |||
Form 4
| -13.24% | -644.00 |
$145.20 | -$93,508.80 | 4.22K |
May 16
| |||
Form 4
| +11.69% | 509 |
$180.00 | -$144,177.50 | 4.87K |
Aug 7 - Aug 10
| |||
Form 4
| -12.98% | -650.00 |
$173.86 | -$113,010.00 | 4.36K |
May 12
| |||
Form 4
| +49.17% | 1.65K |
—
|
—
| 5.01K |
Aug 7
| |||
Form 4
| -16.10% | -644.00 |
$142.49 | -$91,763.56 | 3.36K |
May 28
| |||
Form 4
|
∞
| 4K |
—
|
—
| 4K |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerevel Therapeutics Holdings, Inc. (CERE) Snapshot price: $41.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.70% | 10.46K |
—
|
—
| 56.55K |
Jun 5
| |||
Form 4
| +7.67% | 3.28K |
—
|
—
| 46.09K |
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +50.00% | 14.27K |
—
|
—
| 42.81K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +100.00% | 14.27K |
—
|
—
| 28.54K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eton Pharmaceuticals, Inc. (ETON) Snapshot price: $4.615
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +9.13% | 5K |
$6.00 | $30,000.00 | 59.74K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptinyx Inc. (APTX) Snapshot price: $0.096
EXECUTIVE CHAIRMAN OF THE BOD
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 100K |
$2.23 | $223,000.00 | 100K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4/A
| +69.71% | 252.73K |
$2.53 | -$322,003.22 | 615.26K |
May 17
| |||
Form 4
| +69.71% | 252.73K |
$2.53 | -$322,003.22 | 615.26K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 35K |
$3.00 | $105,000.00 | 35K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +11.90% | 38.56K |
$2.59 | $99,878.17 | 362.54K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
| +58.60% | 121.6K |
$16.00 |
—
| 329.09K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||